• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study.

作者信息

Choi Hayoung, Lee Hyun, Lee Sun-Kyung, Yang Bumhee, Chung Sung Jun, Yeo Yoomi, Park Tai Sun, Park Dong Won, Moon Ji-Yong, Kim Tae-Hyung, Sohn Jang Won, Yoon Ho Joo, Kim Sang-Heon

机构信息

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

出版信息

Ther Adv Respir Dis. 2021 Jan-Dec;15:1753466621995043. doi: 10.1177/1753466621995043.

DOI:10.1177/1753466621995043
PMID:33583345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7890711/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea0/7890711/8ed74498d352/10.1177_1753466621995043-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea0/7890711/8ed74498d352/10.1177_1753466621995043-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea0/7890711/8ed74498d352/10.1177_1753466621995043-fig1.jpg

相似文献

1
Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study.支气管扩张对新型冠状病毒肺炎易感性和严重程度的影响：一项全国性队列研究
Ther Adv Respir Dis. 2021 Jan-Dec;15:1753466621995043. doi: 10.1177/1753466621995043.
2
Impact of Bronchiectasis on Incident Nontuberculous Mycobacterial Pulmonary Disease: A 10-Year National Cohort Study.支气管扩张对非结核分枝杆菌性肺部疾病发病的影响：一项为期10年的全国队列研究。
Chest. 2021 May;159(5):1807-1811. doi: 10.1016/j.chest.2020.12.020. Epub 2020 Dec 26.
3
Prevalence of depression and its associated factors in bronchiectasis: findings from KMBARC registry.支气管扩张症患者抑郁的患病率及其相关因素：来自 KMBARC 登记研究的结果。
BMC Pulm Med. 2021 Sep 27;21(1):306. doi: 10.1186/s12890-021-01675-4.
4
Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.韩国精神疾病与新冠病毒易感性及临床结局之间的关联：一项全国性队列研究。
Lancet Psychiatry. 2020 Dec;7(12):1025-1031. doi: 10.1016/S2215-0366(20)30421-1. Epub 2020 Sep 17.
5
The association between combined non-cystic fibrosis bronchiectasis and lung cancer in patients with chronic obstructive lung disease.慢性阻塞性肺疾病患者中合并非囊性纤维化支气管扩张与肺癌之间的关联。
Int J Chron Obstruct Pulmon Dis. 2015 May 4;10:873-9. doi: 10.2147/COPD.S80439. eCollection 2015.
6
The impact of the COVID-19 pandemic on adult bronchiectasis patients and the relationship between clinical parameters and bronchiectasis severity.COVID-19 大流行对成人支气管扩张症患者的影响，以及临床参数与支气管扩张症严重程度的关系。
Eur Rev Med Pharmacol Sci. 2024 Jul;28(13):3958-3968. doi: 10.26355/eurrev_202407_36528.
7
Being Underweight Increases the Risk of Non-Cystic Fibrosis Bronchiectasis in the Young Population: A Nationwide Population-Based Study.体重过轻会增加年轻人群中非囊性纤维化性支气管扩张症的风险：一项全国范围内基于人群的研究。
Nutrients. 2021 Sep 15;13(9):3206. doi: 10.3390/nu13093206.
8
Evaluating the Prevalence and Incidence of Bronchiectasis and Nontuberculous Mycobacteria in South Korea Using the Nationwide Population Data.利用全国人口数据评估韩国支气管扩张症和非结核分枝杆菌的流行率和发病率。
Int J Environ Res Public Health. 2021 Aug 27;18(17):9029. doi: 10.3390/ijerph18179029.
9
Quantitative computed tomography features and clinical manifestations associated with the extent of bronchiectasis in patients with moderate-to-severe COPD.中重度慢性阻塞性肺疾病患者支气管扩张程度相关的定量计算机断层扫描特征及临床表现
Int J Chron Obstruct Pulmon Dis. 2018 May 1;13:1421-1431. doi: 10.2147/COPD.S157953. eCollection 2018.
10
Trends in the Prevalence of Non-TB Mycobacterial Infection in Patients With Non-Cystic Fibrosis Bronchiectasis in South Korea, 2012-2016.2012 - 2016年韩国非囊性纤维化支气管扩张症患者非结核分枝杆菌感染患病率趋势
Chest. 2021 Mar;159(3):959-962. doi: 10.1016/j.chest.2020.10.093. Epub 2020 Dec 7.

引用本文的文献

1
Exacerbation and mortality risk in individuals with bronchiectasis post-COVID-19 recovery.新冠病毒感染康复后支气管扩张症患者的病情加重及死亡风险
ERJ Open Res. 2025 Jun 30;11(3). doi: 10.1183/23120541.00866-2024. eCollection 2025 May.
2
Clinical Course of Coronavirus disease 2019 C-19 in Patients with Bronchiectasis.支气管扩张症患者的2019冠状病毒病（COVID-19）临床病程
Thorac Res Pract. 2024 Sep 2;25(5):184-187. doi: 10.5152/ThoracResPract.2024.23054.
3
Risk of incident chronic obstructive pulmonary disease during longitudinal follow-up in patients with nontuberculous mycobacterial pulmonary disease.

本文引用的文献

1
Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps.哮喘与 2019 年严重急性呼吸综合征冠状病毒：现有证据与知识缺口。
Curr Opin Pulm Med. 2021 Jan;27(1):45-53. doi: 10.1097/MCP.0000000000000744.
2
Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study.支气管扩张症与依赖皮质类固醇的重症哮喘患者死亡率增加：一项全国性人群研究。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963030. doi: 10.1177/1753466620963030.
3
COVID-19 and COPD.
非结核分枝杆菌肺病患者纵向随访期间新发慢性阻塞性肺疾病的风险。
Respir Res. 2024 Sep 9;25(1):333. doi: 10.1186/s12931-024-02963-3.
4
TAS2R38 Genotype Does Not Affect SARS-CoV-2 Infection in Primary Ciliary Dyskinesia.TAS2R38 基因型不会影响原发性纤毛运动障碍患者中的 SARS-CoV-2 感染。
Int J Mol Sci. 2024 Aug 8;25(16):8635. doi: 10.3390/ijms25168635.
5
A double-blind randomized controlled trial of N-acetylcysteine (NAC) for the treatment of acute exacerbation of chronic obstructive pulmonary disease.一项关于N-乙酰半胱氨酸（NAC）治疗慢性阻塞性肺疾病急性加重期的双盲随机对照试验。
Respirol Case Rep. 2024 Aug 6;12(8):e01449. doi: 10.1002/rcr2.1449. eCollection 2024 Aug.
6
Exacerbations of bronchiectasis.支气管扩张症恶化。
Eur Respir Rev. 2024 Jul 24;33(173). doi: 10.1183/16000617.0085-2024. Print 2024 Jul.
7
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID.英国已有气道疾病患者中新冠病毒住院治疗的长期影响：一项多中心纵向队列研究——PHOSP-COVID
ERJ Open Res. 2024 Jul 15;10(4). doi: 10.1183/23120541.00982-2023. eCollection 2024 Jul.
8
Bronchiectasis and COVID-19: For Better or for Worse?支气管扩张症与2019冠状病毒病：是福是祸？
Ann Am Thorac Soc. 2024 Feb;21(2):208-210. doi: 10.1513/AnnalsATS.202312-1018ED.
9
Symptoms and medical resource utilization of patients with bronchiectasis after SARS-CoV-2 infection.新型冠状病毒感染后支气管扩张症患者的症状及医疗资源利用情况
Front Med (Lausanne). 2024 Jan 8;10:1276763. doi: 10.3389/fmed.2023.1276763. eCollection 2023.
10
Risk of newly diagnosed interstitial lung disease after COVID-19 and impact of vaccination: a nationwide population-based cohort study.COVID-19 后患新发间质性肺病的风险及疫苗接种的影响：一项全国基于人群的队列研究。
Front Public Health. 2024 Jan 8;11:1295457. doi: 10.3389/fpubh.2023.1295457. eCollection 2023.
新型冠状病毒肺炎（COVID-19）与慢性阻塞性肺疾病（COPD）。
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.02108-2020. Print 2020 Aug.
4
Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.过敏疾病与 COVID-19 的易感性和严重程度：一项全国性队列研究。
J Allergy Clin Immunol. 2020 Oct;146(4):790-798. doi: 10.1016/j.jaci.2020.08.008. Epub 2020 Aug 15.
5
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
6
Asthma and COPD in Hospitalized COVID-19 Patients.住院COVID-19患者中的哮喘和慢性阻塞性肺疾病
Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):604-606. doi: 10.1016/j.arbres.2020.05.007. Epub 2020 May 31.
7
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.COPD 与 COVID-19 患者吸烟的流行率、严重程度和死亡率：一项快速系统评价和荟萃分析。
PLoS One. 2020 May 11;15(5):e0233147. doi: 10.1371/journal.pone.0233147. eCollection 2020.
8
Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.韩国 2019 冠状病毒病（COVID-19）实验室诊断指南。
Ann Lab Med. 2020 Sep;40(5):351-360. doi: 10.3343/alm.2020.40.5.351.
9
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响：系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.